Home › Pharmacology › Direct-Acting Antihypertensive Drugs

Direct-Acting Antihypertensive Drugs

For medical students2 min readUpdated 2026-10-10

Direct-acting antihypertensive agents lower blood pressure by directly affecting vascular smooth muscle. This leads to vasodilation of the vascular bed and a reduction in total peripheral resistance.

Site of ActionVascular smooth muscle wall

HemodynamicsReduction in TPR and systemic blood pressure

Side EffectsReflex tachycardia and RAAS activation

ClassificationDivided into 4 main drug groups

Mechanism of Action and Hemodynamics

Peripheral vascular tone is one of the three key factors determining blood pressure levels. Drugs in this group exert a direct spasmolytic effect on vascular smooth muscle. As a result of this action, blood vessels dilate, and total peripheral resistance (TPR) decreases, which naturally leads to a drop in systemic blood pressure.

However, a prolonged or rapid therapeutic effect triggers compensatory mechanisms in the body:

Reflex tachycardia: Develops in response to decreased blood pressure via baroreceptors in the aortic arch and carotid sinus.
Secondary RAAS activation: A drop in renal perfusion stimulates juxtaglomerular cells, increasing renin secretion.
Fluid retention: Long-term use leads to sodium and water accumulation.

Physiological Regulation of Vascular Tone

Under normal conditions, vessel lumen caliber is maintained through a balance of neurohumoral factors:

Neuronal regulation
Mediated by the sympathetic nervous system.
Mechanism involves stimulation of postsynaptic alpha-1 adrenergic receptors.
Net effect: increased tone and vasoconstriction.

Humoral regulation
Includes circulating substances and local factors.
Divided into vasopressor systems that increase tone and vasodilator systems that decrease it.

Endogenous Vasoactive Substances

Understanding pharmacotherapy requires considering natural endogenous regulators of vessel caliber:

Vasoconstrictors:
Monoamines: epinephrine, norepinephrine.
Peptides and hormones: angiotensin II, vasopressin, endothelin, neuropeptide Y.
Arachidonic acid derivatives: thromboxane, prostaglandin F2-alpha.

Vasodilators:
Endothelial factors: endothelium-derived relaxing factor (nitric oxide, NO), prostacyclin.
Peptides: bradykinin, adrenomedullin, natriuretic peptides (types A, B, C).
Mediators and metabolites: acetylcholine, histamine, adenosine, ATP.

Classification of Direct-Acting Vasodilators

Drugs that reduce vascular tone through a direct effect on muscle are divided into 4 groups based on their mechanism of action:

Calcium channel blockers (calcium antagonists).
Potassium channel openers.
Nitric oxide (NO) donors.
Other agents.

Mnemonic

Direct relaxation of vascular smooth muscle decreases TPR, but the body activates defense mechanisms: tachycardia, RAAS, and water retention.

Frequently asked questions

Which drugs belong to calcium channel blockers?

Calcium channel blockers (calcium antagonists) include amlodipine, nifedipine, cinnarizine, and nimodipine.

Amlodipine — a direct-acting agent targeting vascular smooth muscle.
Nifedipine — a calcium channel blocker; classified as a direct-acting agent.
Cinnarizine — a calcium channel blocker affecting cerebral circulation.
Nimodipine — a specific drug with high tropism for cerebral blood vessels.

Which drugs are included in the potassium channel openers group?

The potassium channel openers group includes minoxidil and diazoxide.

Minoxidil — an antihypertensive drug that lowers blood pressure.
Diazoxide — a drug that opens potassium channels in vascular smooth muscle membranes.

Both drugs promote potassium ion efflux from the cell, membrane hyperpolarization, and subsequent relaxation of the vascular wall.

What agents act as nitric oxide donors?

Nitric oxide (NO) donors include sodium nitroprusside and nitroglycerin.

Sodium nitroprusside (Sodium nitroprusside) — releases NO, activates cytosolic guanylyl cyclase, increases cGMP levels, decreases intracellular calcium concentration, and dilates both resistance and capacitance vessels.
Nitroglycerin — acts as a donor of nitric oxide (NO), an endothelial relaxing factor; through guanylyl cyclase activation and cGMP accumulation, it relaxes vascular smooth muscle cells.

What agents are included in the miscellaneous direct-acting drugs group?

The miscellaneous group of direct-acting vasodilators includes direct-acting agents, as well as specific and novel drug classes.

Bendazol — most commonly used as part of combination therapy.
Magnesium sulfate — administered intramuscularly for hypertensive emergencies.
Nesiritide — recombinant B-type natriuretic peptide.

Promising directions and specific agents for acute heart failure also include natriuretic peptide analogs, endothelin antagonists, and vasopressin receptor antagonists.

What is the primary hemodynamic result of direct-acting agents?

A direct spasmolytic effect on vascular smooth muscle dilates vessels, leading to a decrease in total peripheral resistance (TPR) and a drop in systemic blood pressure.

Why does tachycardia occur when taking direct-acting vasodilators?

Reflex tachycardia develops in response to lowered blood pressure via the activation of baroreceptors located in the aortic arch and carotid sinus.

What are the main groups in the classification of direct-acting antihypertensive drugs?

According to their mechanism of action, they are divided into 4 groups: calcium channel blockers, potassium channel openers, nitric oxide (NO) donors, and miscellaneous agents.

Go deeper

Detailed analysis of the role of aortic arch and carotid sinus baroreceptors
Mechanisms of renal juxtaglomerular cell stimulation and RAAS activation
The impact of the sympathetic nervous system and alpha-1 adrenergic receptors on vasoconstriction
The role of endothelial factors and arachidonic acid derivatives in humoral regulation
Pharmacological properties of nitric oxide donors and potassium channel openers